Having achieved the technical standards at our Hyderabad unit, more products have been identified which will enable greater stability for the company and also enable diversification of the product base. Hence we have also taken up an expansion of the facilities to cater to the new products, in Jawaharlal Nehru Pharmacity, Visakhapatnam. These facilities are envisaged to meet US-FDA and cGMP standards.
This company has been given a credit rating of SE-3B by CRISIL. KRR Drugs is also in the advanced stage of compliance to the triple certification of ISO 9001:2000 , ISO:14001:2004 and OHSAS 18000:2007 to meet future quality, environmental and safety related challenges.